Grit Biotherapeutics
PrivateLast Round
Series B
Sep 8, 2023
Total Funding Raised
$75.4M
Company Overview
Grit Biotherapeutics is a biopharmaceutical company that develops tumor-infiltrating lymphocyte (TIL) immunotherapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Grit Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
Grit Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 8, 2023 | ||||
| Series A Extension | Jul 15, 2021 | ||||
| Series A | Dec 1, 2020 |
Grit Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yuanhe Capital | Series B |
| China International Capital Corporation | Series B |
| Decheng Capital | Series B, Series A, Series A Extension |
| Liando Investment | Series B |
| MPCi | Series B, Series A, Series A Extension |
| Sherpa Healthcare Partners | Series B, Series A |
| Apricot Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 8, 2023
$60M round led by China International Capital Corporation.
- Jul 15, 2021
Raised Series A Extension with investors including Apricot Capital and Decheng Capital.
Grit Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Grit Biotherapeutics's valuation, stock price, and market status.
